Top 100 most promising companies in USA by Silicon.
Leverage KOL Sentiment Analysis for Strategic Action
Single platform for Medical and Marketing teams with strict compliance firewalls.
Smooth Slow Scroll with Pause
Top 100 most promising companies in USA by Silicon.
Leverage KOL Sentiment Analysis for Strategic Action.
Single platform for Medical and Marketing teams with strict compliance firewalls.
Book a Demo
By /

Transform HCP Insights into Impact - A Masterclass with Industry Leaders

Holistic Insights for Medical & Commercial Teams: Viewing the HCPs an Integrated Lens

  • 06/08/2025
  • 12:00 PM EST
  • Online
Register Now

Fill the form below to watch the full webinar

Webinar Speakers

Andrea Martins Bayer

Andrea Martins Bayer

American Thoracic Society
Ex. Novartis, GSK

Read Bio
Madoc Walmsley

Madoc Walmsley

Sr. Director, Head of TLL, Alexion Pharmaceuticals Inc

Read Bio

Badal Shah

Founder and President Neolytica
(Moderator)

Read Bio

About Webinar

Transform HCP insights into Impact- A Masterclass with Industry leaders is a webinar series crafted to bring together prominent thought leaders and experts to explore the transformative topics that are shaping the Key External Expert (KEE) engagement insights generating impact measurement and precision communication between pharma and HCPs. Our goal is to provide valuable insights, foster discussion, and drive innovation within the sector.

This session will delve into the dynamic landscape of KEE strategic engagement, exploring the latest trends, challenges, and opportunities. We anticipate a rich discussion covering a range of topics, including:

-Enhancing Collaboration Between Medical and Commercial Teams: Establishing a unified, customer-centric approach that breaks down departmental silos through seamless insight-sharing fosters cross-functional collaboration, enabling informed decision-making and strategic alignment across medical and commercial teams to drive collaborative outcomes for stakeholders.

-Optimizing Data Utilization to Improve Patient Outcomes: Integrating and optimizing medical and commercial data provides holistic insights that empower informed decisions, strategically aligning resources to enhance seamless data sharing and analysis to create a unified view of the customer.

For future Webinar & Event updates subscribe to our newsletter.

Scroll to Top

Andrea Martins Bayer

Andrea brings over 20 years of experience in Medical Affairs, Marketing, and Market Access, working with healthcare organizations across the U.S., Latin America, and Europe.

She has led cross-functional teams and developed strategies that drive results in complex, multicultural environments. Andrea has expertise in leveraging data and AI tools to support strategic decision-making, enhance engagement, and implement long-term plans.

Madoc Walmsley

With over 24 years of experience in the pharmaceutical and biotech industry, Madoc Walmsley has built a diverse and impactful career spanning sales, marketing, and leadership roles. For the past 5 years, Madoc has led a high-performing Thought Leader Liaison team, driving strategic engagement with key opinion leaders to advance medical education and advocacy.

His background includes early experience in the capital equipment and medical device sectors, followed by the last 14 years dedicated to rare diseases—a space where he has found his greatest purpose. Madoc is deeply passionate about improving patient lives, building strong partnerships with the KOL community, and working to shorten the often lengthy and challenging diagnostic journey for those with rare conditions. His commitment to patients and relentless focus on collaboration continue to fuel his mission to bring meaningful change to the rare disease landscape.

Badal Shah

Badal Shah has transformed the approach to affecting successful outcomes inside the arena of thought leadership within health and life sciences. It was his vision to start a subsidiary company completely focused on Data analytics and Artificial intelligence. He will be the Managing Director of Neolytica and responsible for its growth and P&L.

  • Recognized as “Top 100 Healthcare leaders” by International Forum on Advancement in Healthcare (IFAH) and was also nominated for “Forbes 30 under 30” in Healthcare in 2018.
  • Pioneered the innovative approach of “How to achieve effective medical communication and optimize field force during pre and post drug launches” supporting numerous successful drug launches.
  • He was also part of the team to establish KOL mapping business at Veeva systems, before joining QPharma.